A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.

Clinical trial NCT07577817 · RECRUITING

Trial details

NCT number: NCT07577817
Sponsor: Cajal Therapeutics Inc.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Anemia Iron Deficiencies Chronic Kidney Disease

Start date: 2026-06-01
Primary completion: 2026-10-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.